InvestorsHub Logo
Followers 5
Posts 479
Boards Moderated 0
Alias Born 11/18/2010

Re: None

Tuesday, 05/25/2021 9:42:06 AM

Tuesday, May 25, 2021 9:42:06 AM

Post# of 113602
TORONTO, May 25, 2021 -- InvestorsHub NewsWire -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has filed an application with the U.S. Food and Drug Administration ("FDA") to receive Orphan Drug Designation ("ODD") for ketamine to treat amyotrophic lateral sclerosis ("ALS"), also known as Lou Gehrig's disease.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News